Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IDXX | TMO | ISRG | EW | FMS |
| Company | Idexx Laboratories | Thermo Fisher Scientific Inc | Intuitive Surg Inc | Edwards Lifesciences Corp | Fresenius Medical Care Ag ADR |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NYSE |
| Open | 482.20 | 542.95 | 385.27 | 87.20 | 19.23 |
| High | 482.21 | 546.14 | 388.65 | 87.20 | 19.60 |
| Low | 471.42 | 539.17 | 364.17 | 85.38 | 19.23 |
| Last | 476.36 | 544.79 | 366.25 | 85.91 | 19.54 |
| Change | -1.43 | +3.27 | -6.38 | -0.54 | +0.15 |
| % Change | -0.30% | +0.60% | -1.71% | -0.62% | +0.77% |
| Volume | 329,109 | 1,091,256 | 3,032,140 | 2,503,331 | 386,319 |
| 20-Day Average Volume | 392,120 | 1,248,567 | 1,545,104 | 2,936,927 | 312,597 |
| Previous Close | 477.79 | 541.52 | 372.63 | 86.45 | 19.39 |
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 511.81 | 569.40 | 386.17 | 91.71 | 18.96 |
| 20-Day Raw Stochastic | 2.76% | 24.13% | 6.43% | 6.05% | 97.62% |
| 20-Day Relative Strength | 26.47% | 38.73% | 39.95% | 41.44% | 52.59% |
| Weighted Alpha | -7.13 | -1.61 | +22.82 | +4.49 | -14.33 |
| Today's Opinion | 24% Sell | 24% Buy | 40% Buy | 56% Buy | 72% Sell |
| Previous Opinion | 24% Sell | 40% Buy | 56% Buy | 56% Buy | 88% Sell |
| Last Month's Opinion | 56% Buy | 88% Buy | 100% Buy | 88% Buy | 72% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.90% since 04/12/24 | -3.72% since 04/12/24 | -4.70% since 04/12/24 | -4.71% since 04/12/24 | +6.31% since 04/12/24 |
| Low | 471.42 on 04/19/24 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 85.38 on 04/19/24 | 18.48 on 04/16/24 |
| High | 506.57 on 04/15/24 | 570.72 on 04/15/24 | 392.29 on 04/15/24 | 91.73 on 04/15/24 | 19.58 on 04/19/24 |
| 1-Month | |||||
| %Chg | -11.42% since 03/19/24 | -6.61% since 03/19/24 | -6.10% since 03/19/24 | -8.78% since 03/19/24 | +0.10% since 03/19/24 |
| Low | 471.42 on 04/19/24 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 85.38 on 04/19/24 | 18.32 on 04/12/24 |
| High | 543.33 on 03/28/24 | 589.93 on 04/09/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 19.70 on 03/20/24 |
| 3-Month | |||||
| %Chg | -9.62% since 01/19/24 | -1.37% since 01/19/24 | -2.16% since 01/19/24 | +15.77% since 01/19/24 | unch since 01/19/24 |
| Low | 471.42 on 04/19/24 | 529.64 on 04/18/24 | 362.14 on 01/24/24 | 71.92 on 01/25/24 | 18.32 on 04/12/24 |
| High | 583.39 on 03/01/24 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 21.48 on 02/14/24 |
| 6-Month | |||||
| %Chg | +11.21% since 10/19/23 | +15.87% since 10/19/23 | +34.11% since 10/19/23 | +24.54% since 10/19/23 | +12.36% since 10/19/23 |
| Low | 372.50 on 11/01/23 | 415.60 on 10/25/23 | 254.85 on 10/30/23 | 60.57 on 10/30/23 | 16.37 on 10/27/23 |
| High | 583.39 on 03/01/24 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 21.52 on 12/14/23 |
| Key Statistics | |||||
| Market Capitalization, $K | 39,682,372 | 206,705,760 | 132,078,328 | 52,036,584 | 11,378,576 |
| Shares Outstanding, K | 83,054 | 381,714 | 354,449 | 601,927 | 586,827 |
| Annual Sales | 3,660,950,000 | 42,857,000,000 | 7,124,100,000 | 6,004,800,000 | 21,054,650,000 |
| Annual Net Income | 845,040,000 | 5,995,000,000 | 1,798,000,000 | 1,402,400,000 | 540,060,000 |
| Last Quarter Sales | 901,600,000 | 10,886,000,000 | 1,928,300,000 | 1,534,100,000 | 5,371,060,000 |
| Last Quarter Net Income | 194,520,000 | 1,630,000,000 | 606,200,000 | 369,900,000 | 202,510,000 |
| 60-Month Beta | 1.26 | 0.80 | 1.36 | 1.05 | 1.00 |
| Per-Share Information | |||||
| Most Recent Earnings | 2.32 on 02/05/24 | 5.67 on 01/31/24 | 1.50 on 04/18/24 | 0.64 on 02/06/24 | 0.47 on 02/20/24 |
| Latest Earnings Date | 05/01/24 | 04/24/24 | 04/18/24 | 04/25/24 | 05/14/24 |
| Most Recent Dividend | N/A | 0.390 on 03/14/24 | N/A | N/A | 0.415 on 05/17/23 |
| Next Ex-Dividends Date | N/A | 03/14/24 | N/A | N/A | 05/17/24 |
| Ratios | |||||
| Price/Earnings ttm | 47.49 | 25.41 | 82.78 | 34.76 | 13.75 |